Clinical Trials
41
Active:0
Completed:29
Trial Phases
4 Phases
Phase 1:13
Phase 2:7
Phase 3:16
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (38 trials with phase data)• Click on a phase to view related trials
Phase 3
16 (42.1%)Phase 1
13 (34.2%)Phase 2
7 (18.4%)Phase 4
2 (5.3%)Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine
Phase 3
Recruiting
- Conditions
- Allergic Rhinitis
- Interventions
- Drug: Desloratadine / Betamethasone in fixed dose
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 70
- Registration Number
- NCT06916884
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis
Phase 3
Recruiting
- Conditions
- Gout ArthritisGout Attack
- Interventions
- Drug: Etoricoxib + Betamethasone fixed dose
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 72
- Registration Number
- NCT06863701
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm
Phase 3
Recruiting
- Conditions
- Acute Low-back PainMuscle Spasm; Back Pain
- Interventions
- Drug: Etoricoxib + Tizanidine fixed dose
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 136
- Registration Number
- NCT06863662
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation
Phase 3
Recruiting
- Conditions
- Joint PainKnee OsteoarthritisHip Osteoarthritis
- Interventions
- First Posted Date
- 2025-03-07
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 231
- Registration Number
- NCT06863636
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine
Phase 3
Recruiting
- Conditions
- Common Cold
- Interventions
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Laboratorios Silanes S.A. de C.V.
- Target Recruit Count
- 177
- Registration Number
- NCT06531707
- Locations
- 🇲🇽
Laboratorio Silanes, S.A. de C.V., Mexico City, Mexico
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
No news found